Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Ziemlewicz, J. Hinshaw, M. Lubner, C. Brace, M. Alexander, P. Agarwal, F. Lee (2015)
Percutaneous microwave ablation of hepatocellular carcinoma with a gas-cooled system: initial clinical results with 107 tumors.Journal of vascular and interventional radiology : JVIR, 26 1
Shaojie Zhang, P. Hu, Neng Wang, Qiang Shen, A. Sun, M. Kuang, G. Qian (2013)
Thermal Ablation Versus Repeated Hepatic Resection for Recurrent Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology, 20
A. Sasaki, M. Aramaki, K. Kawano, Y. Morii, K. Nakashima, Takanori Yoshida, S. Kitano (1998)
Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatmentBritish Journal of Surgery, 85
Kichang Han, H. Ko, K. Kim, H. Won, Y. Shin, P. Kim (2015)
Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis.Journal of vascular and interventional radiology : JVIR, 26 7
D. Al‐Adra, R. Gill, S.J. Axford, Xinzhe Shi, N. Kneteman, S. Liau (2015)
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysisEuropean Journal of Surgical Oncology, 41
Jin Kim, H. Won, Y. Shin, P. Kim, Sung‐Gyu Lee, Shin Hwang (2011)
Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection.European journal of radiology, 80 3
G. Carrafiello, D. Laganà, E. Cotta, M. Mangini, F. Fontana, F. Bandiera, C. Fugazzola (2010)
Radiofrequency Ablation of Intrahepatic Cholangiocarcinoma: Preliminary ExperienceCardioVascular and Interventional Radiology, 33
T. Atwell, J. Charboneau, F. Que, J. Rubin, B. Lewis, D. Nagorney, M. Callstrom, M. Farrell, H. Pitot, T. Hobday (2005)
Treatment of Neuroendocrine Cancer Metastatic to the Liver: The Role of Ablative TechniquesCardioVascular and Interventional Radiology, 28
Yue-hua Wang, Ya-min Zheng, L. Teng (2013)
Hepatic resection for intrahepatic cholangiocarcinoma after a failed trial of radiofrequency ablation.Chinese medical journal, 126 18
T. Yin, W. Li, P. Zhao, Y. Wang, J. Zheng (2017)
Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma.Clinical radiology, 72 2
M. Haidu, G. Dobrozemsky, P. Schullian, G. Widmann, A. Klaus, H. Weiss, R. Margreiter, R. Bale (2012)
Stereotactic Radiofrequency Ablation of Unresectable Intrahepatic Cholangiocarcinomas: A Retrospective StudyCardioVascular and Interventional Radiology, 35
S. Park, Il Kim, S. Lee, Minwoo Shin, W. Shin, Y. Chung, G. Kim, M. Kim, J. Won, Do Lee, J. Choi, Kwang‐hyub Han (2016)
Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility StudyKorean Journal of Radiology, 17
Muneeb Ahmed, L. Solbiati, C. Brace, D. Breen, M. Callstrom, J. Charboneau, Min-hua Chen, B. Choi, T. Baère, G. Dodd, D. Dupuy, D. Gervais, D. Gianfelice, A. Gillams, F. Lee, E. Leen, R. Lencioni, P. Littrup, T. Livraghi, David Lu, J. McGahan, M. Meloni, B. Nikolic, P. Pereira, P. Liang, H. Rhim, S. Rose, R. Salem, C. Sofocleous, S. Solomon, M. Soulen, Masatoshi Tanaka, T. Vogl, B. Wood, S. Goldberg (2014)
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.Radiology, 273 1
Y. Chiou, J. Hwang, Y. Chou, Hsin-Kai Wang, J. Chiang, Cheng‐Yen Chang (2005)
Percutaneous Ultrasound‐guided Radiofrequency Ablation of Intrahepatic CholangiocarcinomaThe Kaohsiung Journal of Medical Sciences, 21
T. Hori, K. Nagata, S. Hasuike, M. Onaga, M. Motoda, A. Moriuchi, Hisayoshi Iwakiri, H. Uto, J. Kato, A. Ido, K. Hayashi, H. Tsubouchi (2003)
Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablationJournal of Gastroenterology, 38
D. Sacks, Tricia McClenny, J. Cardella, C. Lewis (2003)
Society of Interventional Radiology clinical practice guidelines.Journal of vascular and interventional radiology : JVIR, 14 9 Pt 2
Yasuji Komorizono, M. Oketani, Katsumi Sako, N. Yamasaki, Toshihiko Shibatou, M. Maeda, Kazunori Kohara, Shuhou Shigenobu, K. Ishibashi, T. Arima (2003)
Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablationCancer, 97
L. Poulou, E. Botsa, I. Thanou, P. Ziakas, L. Thanos (2015)
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.World journal of hepatology, 7 8
N. Esnaola, J. Meyer, A. Karachristos, Jennifer Maranki, E. Camp, C. Denlinger (2016)
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinomaCancer, 122
R. Dhanasekaran, A. Hemming, I. Zendejas, T. George, D. Nelson, C. Soldevila‐Pico, R. Firpi, G. Morelli, V. Clark, R. Cabrera (2013)
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinomaOncology Reports, 29
S. Mouli, Khairuddin Memon, Talia Baker, A. Benson, M. Mulcahy, Ramona Gupta, R. Ryu, R. Salem, R. Lewandowski (2013)
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Journal of vascular and interventional radiology : JVIR, 24 8
K. Simo, Laura Halpin, N. McBrier, Jacob Hessey, E. Baker, S. Ross, R. Swan, D. Iannitti, J. Martinie (2016)
Multimodality treatment of intrahepatic cholangiocarcinoma: A reviewJournal of Surgical Oncology, 113
S. Butros, A. Shenoy-Bhangle, P. Mueller, R. Arellano (2014)
Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome.Clinical imaging, 38 4
L. Crocetti, R. Lencioni (2008)
Thermal ablation of hepatocellular carcinomaCancer Imaging, 8
Ming-an Yu, P. Liang, Xiaoling Yu, Zhigang Cheng, Z. Han, Fang-yi Liu, Jie Yu (2011)
Sonography-guided percutaneous microwave ablation of intrahepatic primary cholangiocarcinoma.European journal of radiology, 80 2
H. Park, S. Yun, E. Lee, Seung Lee, Sung-Sik Han, S. Kim, Sang-Jae Park (2016)
Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After SurgeryAnnals of Surgical Oncology, 23
H. Puhalla, B. Schuell, H. Pokorny, G. Kornek, W. Scheithauer, T. Gruenberger (2005)
Treatment and outcome of intrahepatic cholangiocellular carcinoma.American journal of surgery, 189 2
Ying Fu, Wei Yang, Wei Wu, K. Yan, B. Xing, Min-hua Chen (2011)
Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinomaChinese Journal of Cancer Research, 23
E. Koay, B. Odisio, M. Javle, J. Vauthey, C. Crane (2017)
Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Hepatobiliary surgery and nutrition, 6 2
A. Giorgio, G. Calisti, G. Stefano, N. Farella, A. Sarno, F. Amendola, U. Scognamiglio, V. Giorgio (2011)
Radiofrequency ablation for intrahepatic cholangiocarcinoma: retrospective analysis of a single centre experience.Anticancer research, 31 12
Yun Cho, H. Rhim, Y. Ahn, Mi Kim, H. Lim (2006)
Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors.AJR. American journal of roentgenology, 186 5 Suppl
and effective treatment for patients with ICCs and may Purpose: To evaluate the safety and oncologic efficacy of be particularly valuable in unresectable patients, or percutaneous thermal ablation of intrahepatic cholan- those who have already undergone hepatic surgery. giocarcinoma (ICC) and identify risk factors for local Tumor size and ablation modality were not associated tumor progression (LTP). with LTP, whereas primary tumors and superficially Materials and methods: Retrospective review of an located tumors were more likely to subsequently recur. institutional tumor ablation registry demonstrated that 20 patients (9 males, 11 females; mean age Key words: Cholangiocarcinoma—Microwave 62.5 ± 15.8 years) with 50 ICCs (mean size ablation—Radiofrequency ablation—CT 1.8 ± 1.3 cm) were treated with percutaneous radiofre- quency ablation (RFA) or microwave ablation (MWA) between 2006 and 2015. Thirty-eight of the treated ICCs Cholangiocarcinoma is the second most common pri- (76%) were metastases that developed after surgical mary liver malignancy, and intrahepatic cholangiocarci- resection of the primary tumor. Patient demographics, nomas (ICCs) account for approximately 5–10% of all procedure technical parameters, and clinical outcomes cholangiocarcinomas [1, 2]. These tumors are associated were reviewed. A Cox proportional hazards model was with high rates of morbidity and mortality because they used to
Abdominal Radiology – Springer Journals
Published: Jun 4, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.